Inhibiting the NLRP3 Inflammasome
Inflammasomes are protein complexes which are important in several inflammatory diseases. Inflammasomes form part of the innate immune system that triggers the activation of inflammatory cytokines interleukin (IL)-1β and IL-18. The inflammasome most studied in sterile inflammation and non-communicab...
Main Authors: | Lina Y. El-Sharkawy, David Brough, Sally Freeman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/23/5533 |
Similar Items
-
A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
by: Callum AH Docherty, et al.
Published: (2023-01-01) -
LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation
by: Jack P Green, et al.
Published: (2020-11-01) -
Exposure to nickel oxide nanoparticles induces pulmonary inflammation through NLRP3 inflammasome activation in rats
by: Cao Z, et al.
Published: (2016-07-01) -
Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury
by: Natasha Irrera, et al.
Published: (2017-07-01) -
Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018-09-01)